Virginia G Kaklamani

  • 5869 Citations
  • 39 h-Index
19972020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Review article
2019

EMERALD: Phase III trial of elacestrant (RAD1901) vs endocrine therapy for previously treated ER+ advanced breast cancer

Bardia, A., Aftimos, P., Bihani, T., Anderson-Villaluz, A. T., Jung, J., Conlan, M. G. & Kaklamani, V. G., Jan 1 2019, In : Future Oncology. 15, 28, p. 3209-3218 10 p.

Research output: Contribution to journalReview article

Open Access
4 Scopus citations
Open Access
3 Scopus citations

Perspectives on the mechanism of action and clinical application of eribulin for metastatic breast cancer

O'Shaughnessy, J., Kaklamani, V. & Kalinsky, K., May 2019, In : Future Oncology. 15, 14, p. 1641-1653 13 p.

Research output: Contribution to journalReview article

Open Access
1 Scopus citations
2017

Evaluating the Role of Extended Aromatase Inhibitor Therapy in Early Hormone-Positive Breast Cancer

Vyas, O. H. & Kaklamani, V. G., Sep 1 2017, In : Current Breast Cancer Reports. 9, 3, p. 183-187 5 p.

Research output: Contribution to journalReview article

2015

Synchronous primary carcinoma of breast and ovary versus ovarian metastases

Yadav, B. S., Sharma, S. C., Robin, T. P., Sams, S., Elias, A. D., Kaklamani, V., Kelly Marcom, P., Schaefer, S. & Morris, G. J., Apr 1 2015, In : Seminars in Oncology. 42, 2, p. e13-e24

Research output: Contribution to journalReview article

2 Scopus citations
2014

Antipsychotic treatment in breast cancer patients

Rahman, T., Clevenger, C. V., Kaklamani, V., Lauriello, J., Campbell, A., Malwitz, K. & Kirkland, R. S., Jun 1 2014, In : American Journal of Psychiatry. 171, 6, p. 616-621 6 p.

Research output: Contribution to journalReview article

23 Scopus citations
2012

The role of cancer stem cells in breast cancer initiation and progression: Potential cancer stem cell-directed therapies

Economopoulou, P., Kaklamani, V. G. & Siziopikou, K., Nov 1 2012, In : Oncologist. 17, 11, p. 1394-1401 8 p.

Research output: Contribution to journalReview article

48 Scopus citations
2010

Genetic/familial high-risk assessment: Breast and ovarian - Clinical practice guidelines in oncology™

Daly, M. B., Axilbund, J. E., Buys, S., Crawford, B., Farrell, C. D., Friedman, S., Garber, J. E., Goorha, S., Gruber, S. B., Hampel, H., Kaklamani, V., Kohlmann, W., Kurian, A., Litton, J., Marcom, P. K., Nussbaum, R., Offit, K., Pal, T., Pasche, B., Pilarski, R. & 5 others, Reiser, G., Shannon, K. M., Smith, J. R., Swisher, E. & Weitzel, J. N., May 2010, In : JNCCN Journal of the National Comprehensive Cancer Network. 8, 5, p. 562-594 33 p.

Research output: Contribution to journalReview article

Open Access
168 Scopus citations

Lapatinib and breast cancer: Current indications and outlook for the future

Moreira, C. & Kaklamani, V., Aug 1 2010, In : Expert Review of Anticancer Therapy. 10, 8, p. 1171-1182 12 p.

Research output: Contribution to journalReview article

23 Scopus citations
2009

Capecitabine: Treatment options in metastatic breast cancer

Kaklamani, V. G. & Gradishar, W. J., Jul 1 2009, In : Expert Review of Obstetrics and Gynecology. 4, 4, p. 367-376 10 p.

Research output: Contribution to journalReview article

2007

HER2-positive breast cancer: Current and future treatment strategies

Engel, R. H. & Kaklamani, V. G., Jun 12 2007, In : Drugs. 67, 9, p. 1329-1341 13 p.

Research output: Contribution to journalReview article

90 Scopus citations

New insights into breast cancer genetics and impact on patient management

Rosman, D. S., Kaklamani, V. & Pasche, B., Dec 1 2007, In : Current Treatment Options in Oncology. 8, 1, p. 61-73 13 p.

Research output: Contribution to journalReview article

16 Scopus citations
2006

A genetic signature can predict prognosis and response to therapy in breast cancer: Oncotype DX

Kaklamani, V., Dec 19 2006, In : Expert Review of Molecular Diagnostics. 6, 6, p. 803-809 7 p.

Research output: Contribution to journalReview article

41 Scopus citations

Gene expression in breast cancer

Kaklamani, V. G. & Gradishar, W. J., Mar 1 2006, In : Current Treatment Options in Oncology. 7, 2, p. 123-128 6 p.

Research output: Contribution to journalReview article

22 Scopus citations
2005

Adjuvant therapy of breast cancer

Kaklamani, V. G. & Gradishar, W. J., Oct 25 2005, In : Cancer Investigation. 23, 6, p. 548-560 13 p.

Research output: Contribution to journalReview article

14 Scopus citations

Adjuvant therapy of breast cancer

Kaklamani, V. G. & Gradishar, W. J., Oct 1 2005, In : Minerva Ginecologica. 57, 5, p. 521-536 16 p.

Research output: Contribution to journalReview article

3 Scopus citations

Behçet's disease associated with malignancies. Report of two cases and review of the literature

Kaklamani, V. G., Tzonou, A. & Kaklamanis, P. G., Dec 1 2005, In : Clinical and Experimental Rheumatology. 23, 4 SUPPL 38, p. S35-S41

Research output: Contribution to journalReview article

28 Scopus citations

The assessment and management of cancer treatment-related diarrhea

O'Brien, B. E., Kaklamani, V. G. & Benson, A. B., Mar 2005, In : Clinical Colorectal Cancer. 4, 6, p. 375-381 7 p.

Research output: Contribution to journalReview article

21 Scopus citations

The Kumar/Leonard article reviewed

Kaklamani, V. G. & Gradishar, W. J., Oct 1 2005, In : ONCOLOGY. 19, 11, p. 1433-1434 2 p.

Research output: Contribution to journalReview article

Transforming Growth Factor Beta and breast cancer.

Kaklamani, V. & Pasche, B., 2005, In : Cancer treatment and research. 126, p. 129-156 28 p.

Research output: Contribution to journalReview article

8 Scopus citations
2004

Role of TGF-β in cancer and the potential for therapy and prevention

Kaklamani, V. G. & Pasche, B., Aug 2004, In : Expert Review of Anticancer Therapy. 4, 4, p. 649-661 13 p.

Research output: Contribution to journalReview article

44 Scopus citations
2003

Advances in adjuvant chemotherapy for breast cancer: the role of taxanes.

Kaklamani, V. G. & Gradishar, W. J., Jan 2003, In : Journal of the National Comprehensive Cancer Network : JNCCN. 1 Suppl 1, p. S107-118

Research output: Contribution to journalReview article

1 Scopus citations

Epirubicin versus doxorubicin: Which is the anthracycline of choice for the treatment of breast cancer?

Kaklamani, V. G. & Gradishar, W. J., Apr 2003, In : Clinical breast cancer. 4, SUPPL. 1, p. S26-S33

Research output: Contribution to journalReview article

53 Scopus citations

Role of capecitabine (Xeloda ®) in breast cancer

Kaklamani, V. G. & Gradishar, W. J., Apr 2003, In : Expert Review of Anticancer Therapy. 3, 2, p. 137-144 8 p.

Research output: Contribution to journalReview article

22 Scopus citations

TGF-beta signaling alterations in cancer.

Bian, Y., Kaklamani, V., Reich, J. & Pasche, B., 2003, In : Cancer treatment and research. 115, p. 73-94 22 p.

Research output: Contribution to journalReview article

10 Scopus citations
2002

Breast cancer prevention: The risks and benefits of drug therapy

Kaklamani, V. G. & O'Regan, R. M., Jan 1 2002, In : American Journal of Cancer. 1, 3, p. 173-178 6 p.

Research output: Contribution to journalReview article

1 Scopus citations